Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (25)

2024

  1. Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase

    Communications Biology, Vol. 7, Núm. 1

  2. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma

    Best Practice and Research: Clinical Endocrinology and Metabolism

  3. Regulation of Myc transcription by an enhancer cluster dedicated to pluripotency and early embryonic expression

    Nature Communications, Vol. 15, Núm. 1

  4. Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts

    iScience, Vol. 27, Núm. 4

  5. ddPCR Overcomes the CRISPR-Cas13a-Based Technique for the Detection of the BRAF p.V600E Mutation in Liquid Biopsies

    International Journal of Molecular Sciences, Vol. 25, Núm. 20

2023

  1. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

    Blood, Vol. 142, Núm. 20, pp. 1752-1756

  2. Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL

    British Journal of Haematology

  3. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

    Frontiers in immunology, Vol. 14, pp. 1185517

  4. Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma

    Nature Communications, Vol. 14, Núm. 1

  5. Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas

    The Journal of clinical investigation, Vol. 133, Núm. 7

  6. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

  7. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

    Nature Communications, Vol. 14, Núm. 1

2022

  1. A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis

    EMBO molecular medicine, Vol. 14, Núm. 3, pp. e14552

  2. A faecal microbiota signature with high specificity for pancreatic cancer

    Gut, Vol. 71, Núm. 7, pp. 1359-1372

  3. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

  4. Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility

    Science Advances, Vol. 8, Núm. 44

  5. CRISPR Approaches for the Diagnosis of Human Diseases

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  6. Human-specific changes in two functional enhancers of FOXP2

    Cellular and Molecular Biology, Vol. 68, Núm. 11, pp. 16-19

  7. OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells

    Frontiers in Oncology, Vol. 12

  8. The insecticides permethrin and chlorpyrifos show limited genotoxicity and no leukemogenic potential in human and murine hematopoietic stem progenitor cells

    Haematologica